The COVID-19 vaccine protection program in Brazil is putting at risk those who fail to shoot again, while 1.5 million people lack the time to seek protection, according to the Ministry of Health.
Experts say this is mainly due to a recent study from Chile that found the Sinovac Biotech COVID-19 vaccine, which contains 80% of the Brazilian program, with only 16% effective after a single shot.
“Without these two standards, we will not be fully protected or protected for long-term,” Juarez Cunha, head of the Brazilian Society of Immunizations, told Reuters. “We want people to do everything right.”
So far this week, more people are dying on COVID-19 in Brazil than anywhere else in the world, while President Jair Bolsonaro has been sharply criticized for opposing residual methods and pushing for drugs like hydroxychloroquine that have little or no benefit. India now surpasses Brazil in death every day.
In all, COVID-19 has claimed the lives of more than 380,000 people in Brazil, the world’s second-largest death toll after the United States.
The country’s poetic system has repeatedly missed its target due to declining ratings due to delays in production from China and India.
Now, the failure of people to come will receive their second level and another concern.
Experts and officials involved in the campaign said the small amount was seen as a reason for good communication, people either did not realize the importance of a second shot or just forgot where they were supposed to go.
In some cases, he said, people can also be upset by the initial force, which can cause temporary fever and body aches. There have also been long queues at some vaccine sites, which could expose groups at risk of COVID-19.
The Ministry of Health has said it is aware of the problem but did not elaborate on what it is doing to address the problem. He did not respond to a request for comment as to why many had not received their second term.
The ministry said the problem was not caused by a shortage of ammunition, while a second quantity was stolen to ensure timely availability.
But with the second round remaining and promising to bring it back, the ministry changed its direction last month to support the first round of shootings.
This is in stark contrast to Chile, where the defense system has completely changed to setting a second level by making more people shoot for the first time.
South America’s richest economy has a proud record of successful vaccinations and elections have shown that many Brazilians are interested in immunization. But scientists fear that the message about the second shot will not appear.
“People need to wake up and hear every day on the radio, on television, that you have to receive a second dose, so that you don’t miss it,” said Cristina Bonorino, a member of the Brazilian Society’s immune system.
A study in Chile, which analyzed the effectiveness of the vaccine among 10.5 million people, found that the immune system of the flu virus had risen to 67 percent from 16 percent with Sinovac’s second shot. The AstraZeneca vaccine, which manufactures all other inoccines in Brazil, by contrast, is 76% effective two weeks after the first shot.
“If a person does not receive their second dose, there is no guarantee that the vaccine will work,” Bonorino said.